Literature DB >> 959769

Serum bile acid concentrations in patients with liver disease.

O Fausa, E Gjone.   

Abstract

An enzymatic-fluorimetric method using a highly purified 3alpha-hydroxysteroid dehydrogenase (Sterognost-3alpha, Nyco) was used to determine fasting serum bile acid concentrations on 49 occasions in 43 patients with various liver diseases. A two-hour postprandial bile acid determination was carried out on 29 occasions in 27 of the patients. Fasting bile acid concentration correlated significantly both in cholestatic hepatobiliary and in parenchymatous liver disease to serum bilirubin and aspartate aminotransferase (ASAT) but not to alanine aminotransferase (ALAT), alkaline phosphatase, or albumin. The two-hour postprandial bile acid concentration was above normal in all patients with biochemical and/or histological signs of hepatobiliary disease, also when fasting concentration was within normal limits. In parenchymatous liver disease correlations existed between the two-hour postprandial bile acid concentration and bilirubin, ASAT, and ALAT. The sensitivity of serum bile acid estimation was compared to other liver function tests. Both the fasting and the postprandial serum bile acid concentrations tended to be more sensitive tests of hepatobiliary disease than bilirubin, ASAT and ALAT.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 959769

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  25 in total

1.  Immunoassay of serum conjugates of cholic acid in cystic fibrosis.

Authors:  G P Davidson; M Corey; F Morad-Hassel; J M Sondheimer; D Crozier; G G Forstner
Journal:  J Clin Pathol       Date:  1980-04       Impact factor: 3.411

2.  Concentration of serum bile acids as an index of hepatic damage in systemic lupus erythematosus.

Authors:  L Altomonte; A Zoli; L Sommella; P Palumbo; A V Greco; M Magaro
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

3.  Serum bile acids in the diagnosis of hepatobiliary disease.

Authors:  C R Pennington; P E Ross; I A Bouchier
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

4.  Visualization of bile homeostasis using (1)H-NMR spectroscopy as a route for assessing liver cancer.

Authors:  G A Nagana Gowda; Narasimhamurthy Shanaiah; Amanda Cooper; Mary Maluccio; Daniel Raftery
Journal:  Lipids       Date:  2008-11-04       Impact factor: 1.880

5.  Physiological factors influencing serum bile acid levels.

Authors:  M Ponz De Leon; G M Murphy; R H Dowling
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

6.  Serum bile acids in patients with hyperlipidaemia.

Authors:  C R Pennington; P E Ross; M C Bateson; I A Bouchier
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

7.  Familial and nonfamilial benign recurrent cholestiasis distinguished by plasma disappearance of indocyanine green but not cholylglycine.

Authors:  G P van Berge-Henegouwen; D R Ferguson; A F Hofmann; A G De Pagter
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

8.  Radioimmunoassay of serum glycocholic acid, standard laboratory tests of liver function and liver biopsy findings: comparative study of children with liver disease.

Authors:  A Matsui; H T Psacharopoulos; A P Mowat; B Portmann; G M Murphy
Journal:  J Clin Pathol       Date:  1982-09       Impact factor: 3.411

9.  Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.

Authors:  Y Adachi; T Nanno; T Itoh; Y Kurumi; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-08

10.  Cholestatic jaundice in infancy. The importance of familial and genetic factors in aetiology and prognosis.

Authors:  N T Henriksen; P A Drabløs; O Aagenaes
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.